[go: up one dir, main page]

AU2003268353A8 - Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection - Google Patents

Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection

Info

Publication number
AU2003268353A8
AU2003268353A8 AU2003268353A AU2003268353A AU2003268353A8 AU 2003268353 A8 AU2003268353 A8 AU 2003268353A8 AU 2003268353 A AU2003268353 A AU 2003268353A AU 2003268353 A AU2003268353 A AU 2003268353A AU 2003268353 A8 AU2003268353 A8 AU 2003268353A8
Authority
AU
Australia
Prior art keywords
diagnosis
prevention
treatment
streptococcus pneumoniae
active infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003268353A
Other versions
AU2003268353A1 (en
Inventor
Andrew Camilli
David L Hava
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tufts University
Original Assignee
Tufts University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tufts University filed Critical Tufts University
Publication of AU2003268353A1 publication Critical patent/AU2003268353A1/en
Publication of AU2003268353A8 publication Critical patent/AU2003268353A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003268353A 2002-08-30 2003-09-02 Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection Abandoned AU2003268353A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40708202P 2002-08-30 2002-08-30
US60/407,082 2002-08-30
PCT/US2003/027401 WO2004020609A2 (en) 2002-08-30 2003-09-02 Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection

Publications (2)

Publication Number Publication Date
AU2003268353A1 AU2003268353A1 (en) 2004-03-19
AU2003268353A8 true AU2003268353A8 (en) 2004-03-19

Family

ID=31978415

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003268353A Abandoned AU2003268353A1 (en) 2002-08-30 2003-09-02 Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection

Country Status (2)

Country Link
AU (1) AU2003268353A1 (en)
WO (1) WO2004020609A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0407384A (en) 2003-02-14 2006-02-21 Pfizer Prod Inc pyridines-triazoles as anti-inflammatory compounds
WO2006048757A2 (en) * 2004-11-05 2006-05-11 Pharmacia & Upjohn Company Llc Anti-bacterial vaccine compositions
WO2006048753A2 (en) * 2004-11-05 2006-05-11 Pharmacia & Upjohn Company Llc Anti-bacterial vaccine compositions
WO2008039838A2 (en) 2006-09-27 2008-04-03 St. Jude Children's Research Hospital Synthetic streptococcus pneumoniae vaccine
GB0714963D0 (en) * 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
BRPI0907010A2 (en) 2008-02-01 2015-07-07 Sanofi Pasteur Ltd Analysis for the diagnosis of streptococcus pneumoniae
NZ597858A (en) 2009-06-29 2014-01-31 Genocea Biosciences Inc Vaccines and compositions against streptococcus pneumoniae
CN103501808A (en) 2010-12-03 2014-01-08 赛诺菲巴斯德有限公司 Composition for immunization against streptococcus pneumoniae
CN103501809B (en) 2011-01-20 2018-08-10 健诺西生物科学公司 Vaccines and compositions against Streptococcus pneumoniae
CN104321335A (en) * 2012-02-24 2015-01-28 诺华股份有限公司 Pilus proteins and compositions
JP2019503201A (en) * 2015-11-25 2019-02-07 ウェイク フォーレスト ユニバーシティ ヘルス サイエンシーズWake Forest University Health Sciences Pneumococcal inhibitor composition and method of use thereof
US11013793B2 (en) * 2018-09-12 2021-05-25 Affinivax, Inc. Multivalent pneumococcal vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4469026B2 (en) * 1996-10-31 2010-05-26 ヒューマン ジノーム サイエンシーズ,インコーポレイテッド Streptococcus pneumoniae antigens and vaccines

Also Published As

Publication number Publication date
AU2003268353A1 (en) 2004-03-19
WO2004020609A2 (en) 2004-03-11
WO2004020609A3 (en) 2004-07-15
WO2004020609A9 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
AU2002255248A1 (en) Diagnosis, treatment and research of mental disorders
HUP0400477A3 (en) Compounds and methods for treatment and diagnosis of chlamydial infection
ZA200108215B (en) Compositions and methods for treatment of staphylococcal infection.
IL152553A0 (en) Compounds and methods for the treatment and prevention of bacterial infection
AUPR839001A0 (en) Dosage form, device and methods of treatment
AU2003268353A8 (en) Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection
WO2000058475A3 (en) Streptococcus pneumoniae antigens
EP1351699A4 (en) Methods for improved diagnosis and treatment of mycobacterial infections
MXPA03006776A (en) Use of il-18 inhibitors for the treatment and/or prevention of heart disease.
AU2002246545A1 (en) Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes
AU2001259507A1 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
PL371524A1 (en) Combination therapy for the treatment of bacterial infections
AU2003210266A1 (en) Treatment, diagnosis and imaging of disease
AU2003247841A1 (en) Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes
AU4204700A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
AU4654500A (en) Prevention, diagnosis and treatment of lyme disease
AU2003282878A8 (en) Diagnosis of invasive mold infection
AU2002330724A1 (en) Diagnosis, prevention and treatment of cancer
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
AU2002365941A1 (en) Methods of diagnosis, monitoring and treatment of fertility
EP1250145A4 (en) C-ski oncogene-derived peptides for prevention, treatment, and diagnosis of cancer
ZA200108013B (en) Monthly closes for treatment of Streptococcus pneumoniae infections.
WO2002024223A3 (en) Prevention and treatment of streptococcal and staphylococcal infection
AU2003255111A1 (en) The use of n-acetyl-d-glucosamine for preparing medicines for urogenital tract infection's treatment and prevention
WO2003096877A3 (en) Prevention and treatment of streptococcal and staphylococcal infection

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase